The Competition And Markets Authority v Flynn Pharma Ltd & Ors [2019] EWCA Civ 1631

Court of Appeal (Civil Division) · 2019-10-04 · Intellectual Property · cited by 1 · influence score 12/100 Appeal Allowed

Is it still good law? No negative treatment found in this dataset — it has been cited without being doubted or overruled here.

How to cite

Neutral citation format (OSCOLA). Always confirm against the official judgment.

Treatment

Cited · 1

Cited — The Competition And Markets Authority v Flynn Pharma Ltd & Anor (Rev 3) 2020-03-10
“…rising were of considerable public importance not only to the correct approach to be adopted to the pricing of pharmaceutical products, but more generally: See [2019] EWCA Civ 1631 (4th October 2019).…”